Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A look at Moonlake Therapeutic's sonelokimab in patients with moderate-to-severe Palmoplantar pustulosis (PPP) and the interim readout of the Phase 2 LEDA study.

Ticker(s): MLTX

Who's the expert?

Institution: Mount Sinai

Clinical Instructor of Dermatology at Weill Cornell and Mount Sinai.
Treats 30 patients with alopecia areata
Clinical interests include autoimmune and autoinflammatory skin conditions with a specialty in MOHS micrographic surgery.

Interview Goal

This conversation will focus on discussing the potential of sonelokimab in patients with moderate-to-severe Palmoplantar pustulosis (PPP) and the interim readout of the Phase 2 LEDA study.

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.